EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The Impact of Silymarin on Inflammation and Oxidative Stress: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Mahdi Vajdi, Shaghayegh Adeli, Arash Karimi, Vahid Asghariazar, Arezoo Moini Jazani, Ramin Nasimidoost Azgomi

International Journal of Clinical Practice · 2025-01 · 2025 (1)

DOI: 10.1155/ijcp/3985207 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Clinical Practice, online erschienen am 23.01.2025. Verfasst von Mahdi Vajdi und 5 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ardabil University of Medical Sciences.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Numerous studies have investigated into the antioxidant and anti‐inflammatory properties of silymarin, as well as its ability to reduce reactive oxygen species and inflammation biomarkers. The effect of silymarin on inflammation and oxidative stress was investigated using the keywords “milk thistle” OR “Silybum marianum” OR “Silybum” OR “silymarin” OR “Silibinin” AND “MDA” OR “Malondialdehyde” OR “TAC” OR “total antioxidant capacity” OR “IL‐10” OR “Interleukin‐10” OR “IL‐6” OR “Interleukin‐6” OR “TNF‐α” OR “tumor necrosis factor alpha” on the Web of Science, Scopus, Embase, PubMed, and Cochrane Library, up until March 2023. Data were combined using a random‐effects model, and the weighted/standardized mean differences (WMDs/SMDs) with a 95% confidence interval (CI) were used as the overall effect size. Our meta‐analysis indicated that silymarin supplementation resulted in a significant decrease in levels of C‐reactive protein (CRP) (WMD: −3.39 mg/L, 95% CI: −5.99, −0.79, p = 0.01) and malondialdehyde (MDA) (SMD: −1.69, 95% CI: −2.62, −0.76, p < 0.001). Furthermore, silymarin significantly increases IL‐10 (WMD: 2.03 pg/mL; 95% CI: 1.04, 3.01, p < 0.001), superoxide dismutase (SOD) (SMD: 3.39, 95% CI: 1.42, 5.37, p = 0.001), and glutathione peroxidase (GPx) (SMD: 1.94; 95% CI, 0.89 to 2.99; p < 0.001) level. However, silymarin supplementation did not have significant effects on TAC (SMD: 2.91; 95% CI: −0.30, 6.11, p = 0.076) and IL‐6 (WMD: −0.70 pg/mL; 95% CI: −1.42, 0.02, p < 0.056) level. Silymarin supplementation may significantly improve oxidative stress and inflammation in adults by decreasing CRP and MDA and increasing IL‐10, SOD, and GPx. However, additional studies with longer study periods are required to ascertain the long‐term effects of silymarin on oxidative stress and chronic inflammation.

Förderung

  • Ardabil University of Medical Sciences

Zitieren

APA

Vajdi, M., Adeli, S., Karimi, A., Asghariazar, V., Jazani, A. M., & Azgomi, R. N. (2025). The Impact of Silymarin on Inflammation and Oxidative Stress: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. International Journal of Clinical Practice, 2025(1). https://doi.org/10.1155/ijcp/3985207

Vancouver

Vajdi M, Adeli S, Karimi A, Asghariazar V, Jazani AM, Azgomi RN. The Impact of Silymarin on Inflammation and Oxidative Stress: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. International Journal of Clinical Practice. 2025;2025(1). doi:10.1155/ijcp/3985207

BibTeX
@article{Vajdi2025,
  author = {Vajdi, Mahdi and Adeli, Shaghayegh and Karimi, Arash and Asghariazar, Vahid and Jazani, Arezoo Moini and Azgomi, Ramin Nasimidoost},
  title = {The Impact of Silymarin on Inflammation and Oxidative Stress: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials},
  journal = {International Journal of Clinical Practice},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/ijcp/3985207}
}
Kostenlos starten →